University of Ioannina
Ανάλυση των ούρων με φασματοσκοπία πυρηνικού μαγνητικού συντονισμού (NMR) σε ασθενείς με υποουριχαιμία και νεφροτοξικότητα που σχετίζεται με φάρμακα
Abstract
dc:descriptionThe aim of this study was: 1. The evaluation of the tubular function in individuals with primary renal hypouricemia based on the serum and urine biochemical analysis and the metabonomic profile of urine analyzed by 1H NMR spectroscopy. 2. The mutational analysis of SLC22A12 gene in subjects with primary renal hypouricemia originated from Greece. 3. The evaluation of the utility of 1H NMR spectroscopy in the detection of early urine alterations in patients treated with aminoglycosides as well as the detection of any electrolyte abnormalities in these patients. Primary renal hypouricemia (PRH) refers to a rare condition of increased renal urate clearance, caused by an isolated inborn error of membrane transport of urate in the renal proximal tubule. Defects in SLC22A12 gene, which encodes the renal urate transporter URAT1, have been reported to be related with the disease pathogenesis. This is the first study that assessed tubular function in primary renal hypouricemia using NMR-based metabonomic urine analysis. The study groups consisted of 36 unrelated asymptomatic subjects with primary renal hypouricemia, defined as serum uric acid levels (sUA) <2.5 mg/dL and fractional excretion of uric acid (FEUA) >10%, after exclusion of diseases and drugs that may affect urate homeostasis, and 39 sex and age-matched healthy individuals with normal sUA levels (>4.0 mg/dL) and FEUA<10%. Individuals with primary hypouricemia presented similar biochemical profiles to the controls without significant differences with regard to the FE of electrolytes and renal threshold for phosphate excretion. Individuals with primary hypouricemia were differentiated from healthy individuals in the Orthogonal Signal Correction Partial Least-Squares-Discriminant Analysis (OSC/PLS-DA) models of the NMR data with a statistically significant separation. The components that contributed to this separation were the lower levels of hippurate, creatinine and trimethylaminoxide, and the higher levels of phenylalanine, alanine, glycine, glutamate, acetate and of an unidentified metabolite (3.3 ppm) observed in hypouricemic subjects compared with the controls. These data suggest that a more generalized proximal tubular disorder that mimicking a partial Fanconi syndrome may underlie a so far considered selective tubular disorder. To elucidate if SLC22A12 gene mutations are responsible for the low serum uric acid levels in Greek individuals, we performed a mutation analysis in Greek subjects with primary renal hypouricemia. No mutation was found but only a silent nucleotide polymorphism (SNP) 1246T>C (His142His) in exon 2 of the SLC22A12 gene. The absence of SLC22A12 gene mutations in Greek subjects with primary renal hypouricemia may indicate the existence of a novel urate transporter or the possibility that, a genetic mutation that does not cause a change in the amino acid sequence of the resulting protein can still alter the protein’s function. ...........................................................................................................................................
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzovaras, Vasileios
- Τζοβάρας, Βασίλειος
Subjects
dc:subject × 20- Ουρικό οξύ
- Υποουριχαιμία
- Πυρηνικός μαγνητικός συντονισμός
- Νεφροί
- Αμινογλυκοσίδες
- Νεφροτοξικότητα
- Σωληνάρια
- Μεταφορείς
- Urate
- Hypouricaemia
- Nuclear magnetic resonance (NMR)
- Renal
- Aminoglycosides
- Nephrotoxicosis
- Tubules
- Transporters
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22131